Hers vs Wellorithm: Brand-name Wegovy vs Compounded GLP-1 Access
Comparing Hers vs Wellorithm for GLP-1 weight-loss access: Hers focuses on FDA-approved brand-name Wegovy starting at $149/mo with an active membership required; Wellorithm offers compounded semaglutide and tirzepatide starting at $147 with licensed clinicians in all 50 states. Quick verdict: choose Hers for FDA-approved brand medication and an ongoing care team; choose Wellorithm for broader state coverage and compounded options.
Side-by-side summary: what differs most
This comparison examines five key differences between Hers and Wellorithm: medication type and FDA status, pricing structure and transparency, state availability, ongoing clinical support and check-ins, and membership or fee requirements. Each point below uses only the supplied facts.
1. Medication type and regulatory status
Hers: Offers FDA-approved Wegovy, a brand-name semaglutide product. Hers explicitly states no compounded medications and highlights name brand medication, not a compounded product. The source preserves that Ozempic may be prescribed off-label and that Wegovy and Zepbound are FDA-approved for weight loss.
Wellorithm: Offers compounded semaglutide and compounded tirzepatide. The source notes compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellorithm prescribes compounded products after a virtual consultation.
2. Pricing approach and transparency
Hers: Lists prices and examples: Wegovy pill from $149/mo and injectable from $199/mo are shown. The detailed evidence also explains that an active Hers Weight Loss Membership is required and membership fees are billed separately. The source includes multiple example starting prices but clarifies membership and medication are billed separately and a prescription is not guaranteed.
Wellorithm: Promotes starting at $147 and other starting price points, but the FAQ notes that Wellorithm does not publish full pricing on the website and that customers receive a personalized quote after the intake quiz. The evidence therefore supports that Wellorithm has advertised starting rates yet relies on an intake-based quote for final cost.
3. State coverage and clinician availability
Hers: Notes limited availability in some states and that treatment is available only when a licensed clinician determines it is medically appropriate. The source states “Not available in all 50 states” and that prescriptions are required.
Wellorithm: States licensed clinicians in all 50 states. The source frames this as a key advantage for patients in states with limited GLP-1 telehealth options.
4. Ongoing care model and check-ins
Hers: Emphasizes a personalized care team with ongoing dose check-ins as part of the service for brand-name medication. The source repeatedly highlights ongoing dose check-ins and a personalized care team.
Wellorithm: Describes virtual consultations and ongoing virtual check-ins after the initial assessment, with medication shipped to the home. The platform is fully virtual and uses clinician review to determine appropriate compounding and titration.
5. Memberships, fees, and other commitments
Hers: Requires an active Hers Weight Loss Membership for medication access. The source specifies a $39 first month fee and auto-renew at $149/month thereafter as the membership structure captured on the landing page, and that medication is not available without an active membership. It also states membership and medication billed separately.
Wellorithm: States there are no membership or hidden fees in the promotional content and emphasizes “no membership or hidden fees” and fast, free shipping in captured evidence. The source includes promotional claims like a weight loss guarantee and initial starting prices, and notes some promotional discounts in its landing content.
| Criteria | Hers | Wellorithm |
|---|---|---|
| Medication type | FDA-approved Wegovy and brand-name GLP-1; no compounded medications | Compounded semaglutide and tirzepatide only |
| Starting price shown | Wegovy pill from $149/mo; injectable from $199/mo (membership required) | Starting at $147 advertised; final quote given after intake quiz |
| State availability | Not available in all 50 states; prescription required | Licensed clinicians in all 50 states |
| Ongoing care | Personalized care team with ongoing dose check-ins | Virtual consultations and ongoing virtual check-ins; medication shipped to home |
| Membership/fees | Active membership required; membership and medication billed separately | No membership required; promotional claims of no hidden fees |
Check Wellorithm eligibility quiz
How these differences affect your choice
If FDA-approved, brand-name medication and a structured care team with dose check-ins matter most, Hers matches that preference by offering Wegovy and emphasizing a personalized care team. If access across all 50 states and compounded semaglutide or tirzepatide options are the priority, Wellorithm presents broader clinician coverage and compounded formulations with a fully virtual intake and shipping model.
See Hers membership and plan details
Safety and regulatory notes to weigh
Both sources include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Hers highlights FDA-approved Wegovy as not compounded. Wellorithm offers compounded products and explicitly notes their compounded status in its materials. Treatment and prescriptions are available only when a licensed clinician determines it is medically appropriate at both providers.
Conclusion: Hers vs Wellorithm
Hers vs Wellorithm comes down to brand-name FDA approval, membership requirements, and access. Hers provides FDA-approved Wegovy and a personalized care team with listed starting prices but requires an active membership and may not operate in all states. Wellorithm offers compounded semaglutide and tirzepatide, licensed clinicians in all 50 states, and advertised starting prices with a final quote after intake.
Choose Hers if you want FDA-approved, brand-name Wegovy with an emphasized care team and are willing to enroll in the required membership.
Choose Wellorithm if you need a provider with licensed clinicians in all 50 states and access to compounded semaglutide or tirzepatide via a fully virtual model.